Scotiabank

Vosker provides remote area monitoring technology using solar power and artificial intelligence for cutting-edge surveillance solutions. It offers mobile security cameras that operate on 4G/LTE networks and are powered by solar energy, providing surveillance capabilities. These cameras are primarily used in various industries. Vosker was founded in 2018, and headquartered in Victoriaville, Quebec.

Champion Iron is a Canadian iron ore exploration and development company, holding extensive claims in the Labrador Trough region. It focuses on properties such as Fire Lake North and Powderhorn/Gullbridge.

Montreal Mini-Storage provides self-storage facility services such as vehicles, retails, parking and warehousing.

Alvéole is a Montreal-based company founded in 2011 that specializes in installing and maintaining beehives at businesses and schools. The company aims to support organizations in achieving sustainability goals by transforming underutilized spaces into environments conducive to bees, including pollinator habitats and bee-friendly gardens. In addition to beekeeping services, Alvéole produces and retails honey, soap bars, lip balms, and food wraps, thereby promoting the use of natural products. The company also offers educational programs focused on biodiversity and environmental stewardship, catering to both corporate clients and educational institutions. Through its initiatives, Alvéole fosters a deeper connection between urban spaces and nature, enhancing ecological awareness and engagement within the community.

Foodtastic is a Quebec-based franchisor that operates a diverse portfolio of restaurant concepts, including La Belle et La Boeuf, Carlos & Pepe's, Souvlaki Bar, Nickels, and Bacaro. With over 900 restaurants in its system generating more than $830 million in sales, Foodtastic is a prominent player in the restaurant industry. The company provides a variety of culinary styles and beverages, creating entertaining dining experiences for its customers. Additionally, Foodtastic is expanding its reach internationally, boasting over 100 restaurants outside of Canada.

The Creative Destruction Lab (CDL) is a seed-stage acceleration program founded in 2012 at the Rotman School of Management in Toronto, Canada. It is dedicated to supporting massively scalable, science- and technology-based ventures by providing a unique coaching process focused on specific objectives. CDL connects startups with experienced entrepreneurs and leading scientists across various sectors, including artificial intelligence, healthcare, quantum computing, blockchain, energy, and cleantech. The program has expanded its reach, operating in six cities: Vancouver, Calgary, Toronto, Montreal, Halifax, and New York City, and emphasizes the commercialization of scientific and technological advancements.

Nuvei is a payments technology company that provides payment solutions to merchants and partners worldwide. It offers the Native Commerce Platform, a cloud-based system for accepting payments across mobile or in-app, online, unattended, and in-store channels. The company supports a range of services, including payout options, card issuing, banking, risk management, and fraud management, delivered through a modular, scalable technology platform. Nuvei serves customers across North America, Europe, the Middle East and Africa, Latin America, and the Asia Pacific region, and works with a network of direct sellers and channel partners such as resellers, software vendors, and marketplaces. Founded in 2003 and headquartered in Montreal, it focuses on enabling next-generation payments and expanding global acceptance for its clients.

Groupe 3737 is an entrepreneurial innovation and diversity hub located in the heart of Montreal’s Saint-Michel neighborhood.

Jarislowsky Fraser Limited is a registered portfolio management firm headquartered in Montreal, Quebec, established in 1955 originally as a research boutique. The firm specializes in investment counseling, managing a diverse range of client portfolios, including those of pension funds, foundations, endowments, corporations, and individual investors in Canada, the United States, and internationally. With over US$32 billion in assets under management, Jarislowsky Fraser operates entirely independently, maintaining no affiliations other than its wholly-owned subsidiary in the United States. The firm provides customized equity, fixed income, and balanced portfolios tailored to the specific needs of its clients, as well as launching and managing various mutual funds. Registered as an Investment Advisor with the Securities and Exchange Commission since 1991, Jarislowsky Fraser has established a reputation for its client-focused investment strategies.

NextAI is an accelerator and founder development program based in Montréal and Toronto, designed for early-stage AI-enabled startups. It targets exceptional teams and individuals from around the globe who aim to commercialize AI research and establish global enterprises. As an innovation hub, NextAI leverages Canada's strong position in artificial intelligence to provide these startups with essential resources, including capital, mentorship, education, and a robust network of business leaders and entrepreneurs. Participating teams can access up to $200,000 in funding, guidance from renowned faculty and scientists, and state-of-the-art AI tools, all aimed at fostering disruptive innovation in various industries.

Liminal BioSciences Inc. is a clinical-stage biopharmaceutical company that specializes in the discovery, development, and commercialization of innovative treatments for patients with unmet medical needs, particularly focusing on rare and orphan diseases. The company operates through two main segments: Small Molecule Therapeutics and Plasma Derived Therapeutics. Its lead product candidate, fezagepras, targets idiopathic pulmonary fibrosis, respiratory diseases, and Alström Syndrome. In the Plasma Derived Therapeutics segment, Liminal BioSciences offers a Plasma Protein Purification System for extracting and purifying therapeutic proteins from human plasma and is developing Ryplazim for congenital plasminogen deficiency. Founded in 1992 and headquartered in Laval, Quebec, the company has a presence in Canada, the United Kingdom, and the United States. It was previously known as Prometic Life Sciences Inc. before rebranding in October 2019.